A clinical research study is now enrolling adults age 60 and older to evaluate an investigational vaccine designed to help prevent illness caused by norovirus.
Norovirus Vaccine Study – Adults 60+
Age Range:
60 to 100
Gender:
Male and Female
Location:
Rochester, New York
About the Study
Norovirus is a common cause of stomach illness that can lead to symptoms such as nausea, vomiting, diarrhea, and stomach pain.
This Phase 3 clinical research study is evaluating the safety and effectiveness of an investigational vaccine for the prevention of illness caused by norovirus. The protocol describes the study as randomized and placebo-controlled, with participants receiving a single injection of either the investigational vaccine or placebo.
Participation includes study visits and follow-up with the research team.
Compensation may be available for qualified participants.
Complete the form to learn more and speak with a study specialist about whether you may qualify.
Qualifications
You May Qualify If You:
- Are 60 years of age or older
- Are interested in participating in norovirus vaccine research
- Are willing and able to complete study visits and follow-up activities
Additional eligibility requirements will apply.
FEATURED STUDIES
Adults 18 years of age and older with elevated inflammation levels and heart disease or certain health conditions that increase […]
A clinical research study is now enrolling people who may be at higher risk for complications from the flu.
A clinical research study is now enrolling adults age 60 and older to evaluate an investigational vaccine designed to help […]
An upcoming clinical research study is evaluating an investigational long-acting approach designed to help prevent influenza. Join our interest list […]
Adults 65 and older may qualify for a clinical research study evaluating an investigational seasonal flu vaccine.
This clinical trial will help us learn if receiving another dose of the RSV vaccine is safe and can help […]